Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H21ClN4O4 |
| Molecular Weight | 440.88 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC1=C(Cl)C=C(C=N1)C2=NC(=NO2)C3=CC=CC4=C3C=CN4CCCC(O)=O
InChI
InChIKey=NFIGDBFIDKDNIG-UHFFFAOYSA-N
InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H,28,29)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Second generation S1P pathway modulators: research strategies and clinical developments. | 2014 May |
|
| Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers. | 2014 May |
|
| Sphingosine 1-phosphate receptor modulators in multiple sclerosis. | 2015 Jul |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB11987
Created by
admin on Sat Dec 16 11:36:47 GMT 2023 , Edited by admin on Sat Dec 16 11:36:47 GMT 2023
|
PRIMARY | |||
|
24988201
Created by
admin on Sat Dec 16 11:36:47 GMT 2023 , Edited by admin on Sat Dec 16 11:36:47 GMT 2023
|
PRIMARY | |||
|
1034688-30-6
Created by
admin on Sat Dec 16 11:36:47 GMT 2023 , Edited by admin on Sat Dec 16 11:36:47 GMT 2023
|
PRIMARY | |||
|
300000041321
Created by
admin on Sat Dec 16 11:36:47 GMT 2023 , Edited by admin on Sat Dec 16 11:36:47 GMT 2023
|
PRIMARY | |||
|
NJL503AIJA
Created by
admin on Sat Dec 16 11:36:47 GMT 2023 , Edited by admin on Sat Dec 16 11:36:47 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
